Retroperitoneal germ cell tumor diagnosed by endoscopic ultrasound-guided fine needle aspiration

ανά Womeldorph, Craig M, Zalupski, Mark M, Knoepp, Stewart M, Soltani, Mohammad, Elmunzer, B Joseph
Έκδοση 2010

Using (18)F Fluorodeoxyglucose Positron Emission Tomography (FDG PET) to Monitor Clinical Outcomes in Patients Treated with Neoadjuvant Chemo-Radiotherapy for Locally Advanced Panc...

ανά Choi, Minsig, Heilbrun, Lance K., Venkatramanamoorthy, Raghu, Lawhorn-Crews, Jawana M., Zalupski, Mark M., Shields, Anthony F.
Έκδοση 2010

A phase II study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil in patients with metastatic pancreatic and biliary cancers

ανά Davis, Elizabeth J., Griffith, Kent A., Kim, Edward J., Ruch, Joshua M., McDonnell, Kevin J., Zalupski, Mark M.
Τόπος έκδοσης Am J Clin Oncol (2018)

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy

ανά HAMMAD, Nazik, HEILBRUN, Lance K, PHILIP, Philip A, SHIELDS, Anthony F, ZALUPSKI, Mark M, VENKATRAMANAMOORTHY, Raghu, EL-RAYES, Bassel F
Έκδοση 2010

A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer

ανά Gartner, Elaina M., Griffith, Kent A., Pan, Quintin, Brewer, George J., Henja, Gwen F., Merajver, Sofia D., Zalupski, Mark M.
Έκδοση 2008

DEPTOR has growth suppression activity against pancreatic cancer cells

ανά Li, Hua, Sun, Grace Y., Zhao, Yongchao, Thomas, Dafydd, Greenson, Joel K., Zalupski, Mark M., Ben-Josef, Edgar, Sun, Yi
Τόπος έκδοσης Oncotarget (2014)

Neoadjuvant Stereotactic Body Radiation Therapy (SBRT), Capecitabine, and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma

ανά Welling, Theodore H., Feng, Mary, Wan, Shanshan, Hwang, Sin Ye, Volk, Michael L., Lawrence, Theodore S., Zalupski, Mark M., Sonnenday, Christopher J.
Έκδοση 2013

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

ανά Davis, Elizabeth J., Zhao, Lili, Lucas, David R., Schuetze, Scott M., Baker, Laurence H., Zalupski, Mark M., Thomas, Dafydd, Chugh, Rashmi
Τόπος έκδοσης BMC Cancer (2016)

Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concur...

ανά Vainshtein, Jeffrey M., Schipper, Matthew, Zalupski, Mark M., Lawrence, Theodore S., Abrams, Ross, Francis, Isaac R., Khan, Gazala, Leslie, William, Ben-Josef, Edgar
Έκδοση 2012

Carbohydrate Antigen 19-9 Is a Prognostic and Predictive Biomarker in Patients With Advanced Pancreatic Cancer Who Receive Gemcitabine-Containing Chemotherapy: A Pooled Analysis of...

ανά Bauer, Todd M., El-Rayes, Bassel F., Li, Xiaobai, Hammad, Nazik, Philip, Philip A., Shields, Anthony F., Zalupski, Mark M., Bekaii-Saab, Tanios
Τόπος έκδοσης Cancer (2012)

Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy

ανά Cuneo, Kyle C., Morgan, Meredith A., Griffith, Kent A., Hawkins, Peter G., Greenson, Joel K., Ben-Josef, Edgar, Lawrence, Theodore S., Zalupski, Mark M.
Τόπος έκδοσης Int J Radiat Oncol Biol Phys (2017)

Original Article A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

ανά Cohen, Steven J., Zalupski, Mark M., Modiano, Manuel R., Conkling, Paul, Patt, Yehuda Z., Davis, Peg, Dorr, Robert T., Boytim, Michelle L., Hersh, Evan M.
Έκδοση 2009

A Phase I Trial of Cabozantinib and Gemcitabine in Advanced Pancreatic Cancer

ανά Zhen, David B, Griffith, Kent A, Ruch, Joshua M, Camphausen, Kevin, Savage, Jason E, Kim, Edward J, Sahai, Vaibhav, Simeone, Diane M, Zalupski, Mark M
Τόπος έκδοσης Invest New Drugs (2016)

Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial

ανά Sahai, Vaibhav, Catalano, Paul J., Zalupski, Mark M., Lubner, Sam Joseph, Menge, Mark R., Nimeiri, Halla Sayed, Munshi, Hidayatullah G., Benson, Al Bowen, O’Dwyer, Peter J.
Τόπος έκδοσης JAMA Oncol (2018)

Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer

ανά El-Rayes, Bassel F., Zalupski, Mark M., Manza, Stephanie G., Rusin, Barbara, Ferris, Ann Marie, Vaishampayan, Ulka, Heilbrun, Lance K., Venkatramanamoorthy, Raghu, Shields, Anthony F., Philip, Philip A.
Έκδοση 2007

Quality of life in a prospective multi-center phase II trial of neoadjuvant full dose gemcitabine, oxaliplatin and radiation in patients with resectable or borderline resectable pa...

ανά Serrano, Pablo E., Herman, Joseph M., Griffith, Kent A., Zalupski, Mark M, Kim, Edward J., Bekaii-Saab, Tanios S., Ben-Josef, Edgar, Dawson, Laura A., Ringash, Jolie, Wei, Alice C.
Τόπος έκδοσης Int J Radiat Oncol Biol Phys (2014)

Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Canc...

ανά Tran, Nguyen H., Sahai, Vaibhav, Griffith, Kent A., Nathan, Hari, Kaza, Ravi, Cuneo, Kyle C., Shi, Jiaqi, Kim, Edward, Sonnenday, Christopher J., Cho, Clifford S., Lawrence, Theodore S., Zalupski, Mark M.
Τόπος έκδοσης Int J Radiat Oncol Biol Phys (2019)

A phase I/II trial of intensity-modulated radiation (IMRT) dose escalation with concurrent fixed- dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer

ανά Ben-Josef, Edgar, Schipper, Mathew, Francis, Isaac R, Hadley, Scott, Ten-Haken, Randall, Lawrence, Theodore, Normolle, Daniel, Simeone, Diane M., Sonnenday, Christopher, Abrams, Ross, Leslie, William, Khan, Gazala, Zalupski, Mark M.
Έκδοση 2012

The Quality-of-Life Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

ανά Herman, Joseph M., Narang, Amol K., Griffith, Kent A., Zalupski, Mark M., Reese, Jennifer B., Gearhart, Susan L., Azad, Nolifer S., Chan, June, Olsen, Leah, Efron, Jonathan E., Lawrence, Theodore S., Ben-Josef, Edgar
Έκδοση 2012

Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

ανά Kim, Edward J., Sahai, Vaibhav, Abel, Ethan V., Griffith, Kent A., Greenson, Joel K., Takebe, Naoko, Khan, Gazala N., Blau, John L., Craig, Ronald, Balis, Ulysses G., Zalupski, Mark M., Simeone, Diane M.
Τόπος έκδοσης Clin Cancer Res (2014)